Literature DB >> 35343783

Functional and Highly Cross-Linkable HIV-1 Envelope Glycoproteins Enriched in a Pretriggered Conformation.

Hanh T Nguyen1,2, Alessandra Qualizza1, Saumya Anang1,2, Meiqing Zhao1, Shitao Zou1, Rong Zhou1, Qian Wang1,2, Shijian Zhang1,2, Ashlesha Deshpande3,4, Haitao Ding3,4, Ta-Jung Chiu5, Amos B Smith5, John C Kappes3,4, Joseph G Sodroski1,2.   

Abstract

Binding to the receptor, CD4, drives the pretriggered, "closed" (state-1) conformation of the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) trimer into more "open" conformations (states 2 and 3). Broadly neutralizing antibodies, which are elicited inefficiently, mostly recognize the state-1 Env conformation, whereas the more commonly elicited poorly neutralizing antibodies recognize states 2/3. HIV-1 Env metastability has created challenges for defining the state-1 structure and developing immunogens mimicking this labile conformation. The availability of functional state-1 Envs that can be efficiently cross-linked at lysine and/or acidic amino acid residues might assist these endeavors. To that end, we modified HIV-1AD8 Env, which exhibits an intermediate level of triggerability by CD4. We introduced lysine/acidic residues at positions that exhibit such polymorphisms in natural HIV-1 strains. Env changes that were tolerated with respect to gp120-gp41 processing, subunit association, and virus entry were further combined. Two common polymorphisms, Q114E and Q567K, as well as a known variant, A582T, additively rendered pseudoviruses resistant to cold, soluble CD4, and a CD4-mimetic compound, phenotypes indicative of stabilization of the pretriggered state-1 Env conformation. Combining these changes resulted in two lysine-rich HIV-1AD8 Env variants (E.2 and AE.2) with neutralization- and cold-resistant phenotypes comparable to those of natural, less triggerable tier 2/3 HIV-1 isolates. Compared with these and the parental Envs, the E.2 and AE.2 Envs were cleaved more efficiently and exhibited stronger gp120-trimer association in detergent lysates. These highly cross-linkable Envs enriched in a pretriggered conformation should assist characterization of the structure and immunogenicity of this labile state. IMPORTANCE The development of an efficient vaccine is critical for combating HIV-1 infection worldwide. However, the instability of the pretriggered shape (state 1) of the viral envelope glycoprotein (Env) makes it difficult to raise neutralizing antibodies against HIV-1. Here, by introducing multiple changes in Env, we derived two HIV-1 Env variants that are enriched in state 1 and can be efficiently cross-linked to maintain this shape. These Env complexes are more stable in detergent, assisting their purification. Thus, our study provides a path to a better characterization of the native pretriggered Env, which should assist vaccine development.

Entities:  

Keywords:  chemical cross-link; envelope; human immunodeficiency virus; native conformation; polymorphism; stabilizing mutation; state 1

Mesh:

Substances:

Year:  2022        PMID: 35343783      PMCID: PMC9044932          DOI: 10.1128/jvi.01668-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  183 in total

1.  CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

Authors:  A Trkola; T Dragic; J Arthos; J M Binley; W C Olson; G P Allaway; C Cheng-Mayer; J Robinson; P J Maddon; J P Moore
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

2.  Distance restraints from crosslinking mass spectrometry: mining a molecular dynamics simulation database to evaluate lysine-lysine distances.

Authors:  Eric D Merkley; Steven Rysavy; Abdullah Kahraman; Ryan P Hafen; Valerie Daggett; Joshua N Adkins
Journal:  Protein Sci       Date:  2014-04-03       Impact factor: 6.725

3.  Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

Authors:  J R Mascola; M G Lewis; G Stiegler; D Harris; T C VanCott; D Hayes; M K Louder; C R Brown; C V Sapan; S S Frankel; Y Lu; M L Robb; H Katinger; D L Birx
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.

Authors:  C C LaBranche; T L Hoffman; J Romano; B S Haggarty; T G Edwards; T J Matthews; R W Doms; J A Hoxie
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence.

Authors:  Brian M Taylor; J Scott Foulke; Robin Flinko; Alonso Heredia; Anthony DeVico; Marvin Reitz
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103

6.  Dual Pathways of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trafficking Modulate the Selective Exclusion of Uncleaved Oligomers from Virions.

Authors:  Shijian Zhang; Hanh T Nguyen; Haitao Ding; Jia Wang; Shitao Zou; Lihong Liu; Debjani Guha; Dana Gabuzda; David D Ho; John C Kappes; Joseph Sodroski
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

7.  Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality.

Authors:  David Beauparlant; Peter Rusert; Carsten Magnus; Claus Kadelka; Jacqueline Weber; Therese Uhr; Osvaldo Zagordi; Corinna Oberle; Maria J Duenas-Decamp; Paul R Clapham; Karin J Metzner; Huldrych F Günthard; Alexandra Trkola
Journal:  PLoS Pathog       Date:  2017-03-06       Impact factor: 6.823

8.  Structural Constraints at the Trimer Apex Stabilize the HIV-1 Envelope in a Closed, Antibody-Protected Conformation.

Authors:  Christina Guzzo; Peng Zhang; Qingbo Liu; Alice L Kwon; Ferzan Uddin; Alexandra I Wells; Hana Schmeisser; Raffaello Cimbro; Jinghe Huang; Nicole Doria-Rose; Stephen D Schmidt; Michael A Dolan; Mark Connors; John R Mascola; Paolo Lusso
Journal:  mBio       Date:  2018-12-11       Impact factor: 7.867

Review 9.  Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective.

Authors:  Katrina Lythgoe; Sebastian Bonhoeffer; Christophe Fraser; Gabriel E Leventhal; George Shirreff; T Déirdre Hollingsworth; Samuel Alizon
Journal:  Science       Date:  2014-03-21       Impact factor: 47.728

10.  Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins.

Authors:  Torben Schiffner; Jesper Pallesen; Rebecca A Russell; Jonathan Dodd; Natalia de Val; Celia C LaBranche; David Montefiori; Georgia D Tomaras; Xiaoying Shen; Scarlett L Harris; Amin E Moghaddam; Oleksandr Kalyuzhniy; Rogier W Sanders; Laura E McCoy; John P Moore; Andrew B Ward; Quentin J Sattentau
Journal:  PLoS Pathog       Date:  2018-05-10       Impact factor: 6.823

View more
  2 in total

1.  Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound.

Authors:  Saumya Anang; Jonathan Richard; Catherine Bourassa; Guillaume Goyette; Ta-Jung Chiu; Hung-Ching Chen; Amos B Smith; Navid Madani; Andrés Finzi; Joseph Sodroski
Journal:  J Virol       Date:  2022-08-18       Impact factor: 6.549

2.  Global Increases in Human Immunodeficiency Virus Neutralization Sensitivity Due to Alterations in the Membrane-Proximal External Region of the Envelope Glycoprotein Can Be Minimized by Distant State 1-Stabilizing Changes.

Authors:  Qian Wang; Florian Esnault; Meiqing Zhao; Ta-Jung Chiu; Amos B Smith; Hanh T Nguyen; Joseph G Sodroski
Journal:  J Virol       Date:  2022-03-15       Impact factor: 6.549

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.